We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Link Technologies Announces Partnership with American International Chemical

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Link Technologies Announces Partnership with American International Chemical"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Link Technologies Ltd has announced that it will partner with American International Chemical (AIC) to distribute Link-branded products in North America.

AIC will offer a sub-set of Link’s specialist oligonucleotide reagents, focusing on the bulk market for oligonucleotide modifiers.

The large-scale purchase of such reagents is of interest to companies who produce large volumes of oligonucleotides for use in life science research and drug discovery.

Link Technologies’ synthesizes high quality reagents for DNA, RNA, PNA & UNA synthesis and modification.

Initially, AIC will distribute Link’s modified phosphoramidites, including dyes and labels, and CPG solid supports through its Advanced Technology Division.

As part of the non-exclusive agreement, Link Technologies will maintain direct contact with existing and new customers in North America at customers’ discretion, and will continue to provide expert technical support to all North American customers.

Dr John Bremner, Business Development Director at Link Technologies, commented: “We are delighted to be working with AIC to expand the availability of our specialist oligonucleotide precursors in the US and Canada. Working at the cutting-edge of nucleotide chemistry, our products are highly regarded for their quality and reliability, and early feedback suggests that customers in North America are enthusiastic about having local access to our portfolio via a well-known and trusted distributor such as AIC. As a manufacturer, though, we know it can be critical for customers to be able to retain contact with us as a key part of the supply-chain, therefore we are still providing that option. It is all about choice.”

Ralph Walker, Director, Advanced Technology at AIC, said: “As one of the largest suppliers to the oligonucleotide and phosphoramidite market over the last twenty years, we are dedicated to providing our customers with reagents of the highest possible quality and purity. This new agreement allows us to expand our Advanced Technology product portfolio to include specialist modifiers, and ensures that we can provide our customers with a reliable and consistent supply chain from an internationally renowned source.”

AIC are hosting a booth at this year’s TIDES Oligonucleotide and Peptide Research, Technology and Product Development Meeting in Las Vegas (20-23 May), where it will be showcasing the new product offering (Booth 227).

Link’s Technical Manager, Dr Catherine McKeen, will also be at the conference, where she will be sharing her expertise as a panellist during a discussion session entitled ‘The Oligo Supply Chain for Diagnostics - Getting your Research to the Market’ (Wednesday, May 23rd at 11:30 am).